Biotechnology

Applied UV Continues International Expansion with Airocide(R) Hospital Installation in Thailand

July 21, 2021 8:30 AM

Airocide® technology helps hospitals to remain open to protect patients, visitors and staff MOUNT VERNON, NY / ACCESSWIRE / July 21, 2021 / Applied UV, Inc. (NASDAQ:AUVI) ("Applied UV" or the "Company"), an infection control technology company that applies the power of narrow-range ultraviolet light ("UVC") for surface areas and catalytic bioconversion technology for air purification to destroy pathogens safely, thoroughly, and automatically,...

Read more

Lexaria's DehydraTECH Significantly Enhances Delivery of Colchicine in Study VIRAL-A20-3

July 21, 2021 7:05 AM

Possible Benefits for Treating SARS-CoV-2/COVID-19 and mRNA Vaccine Side Effects KELOWNA, BC / ACCESSWIRE / July 21, 2021 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms is pleased to announce that its tolerability and pharmacokinetic study VIRAL-A20-3 has been completed with positive results. This study demonstrated that DehydraTECHTM enabled colchicine, the...

Read more

Pressure BioSciences to Expand on Recent UST Platform Breakthroughs and Impending Agrochem Asset Acquisition at Upcoming Emerging Growth Conference

July 20, 2021 10:45 AM

Company Invites Investors, Analysts, and Advisors to Attend Its Real-Time, Interactive UST Platform and Agrochem Asset Acquisition Update, Followed by a Q&A Session, on Wednesday, July 21, 2021 SOUTH EASTON, MA / ACCESSWIRE / July 20, 2021 / Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBI" and the "Company"), a leader in the development and sale of innovative, broadly enabling, pressure-based instruments, consumables, and services to the worldwide...

Read more

Sense Appoints Timothy I. Still as President, CEO and Board Member

July 20, 2021 9:00 AM

Appointment of industry veteran to accelerate commercialization of company's instrument-free molecular testing platform BOSTON, MA / ACCESSWIRE / July 20, 2021 / Sense Biodetection, innovator of instrument-free, rapid molecular tests that enable improved patient access and enhanced clinical value through patient-focused decentralized testing, today announced the appointment of Timothy I. Still as President and Chief Executive Officer. Still will...

Read more

Thermic Science Proudly Files All Required Financials & Report Filings Ahead of Schedule to Bring the Company to Pink Current Status and in Compliance with the OTC Market Reporting Changes the New Rule 15c2-11 Amendments before the September 2021 Deadline

July 20, 2021 8:35 AM

NASHVILLE, TN / ACCESSWIRE / July 20, 2021 / Thermic Science International Corporation, formerly known as Omnicanna Health Solutions, Inc. aka Endocan Corporation. (WKN:A1W61J) (ISIN:US29271J1097) (OTC:ENDO), is proud to announce it has officially filed all required financials & reporting requirements ahead of schedule to bring the Company current and in compliance with the OTC Market Exchange and the new Amendments to Rule 15c2-11 before the...

Read more

Enzolytics Announces the Signing of a Letter of Intent with Creative Biolabs, Inc. for Licensing and Commercialization of anti-HTLV-1 Monoclonal Antibodies

July 20, 2021 7:30 AM

COLLEGE STATION, TX / ACCESSWIRE / July 20, 2021 / Enzolytics, Inc. (OTC PINK:ENZC) ("Enzolytics" and the 'Company') announces the signing of a Letter of Intent (LOI) with Creative Biolabs ("Creative") (https://www.creative-biolabs.com) to complete the joint production and commercialization of HTLV-1 monoclonal antibodies by combining the technologies of the companies. There are no effective vaccines against HTLV-1 and no antiviral drugs...

Read more

Oncology Pharma, Inc. To Move to Conducting Trials on Licensed IP

July 20, 2021 7:30 AM

SAN FRANCISCO, CA / ACCESSWIRE / July 20, 2021 / Oncology Pharma Inc. (OTC PINK:ONPH) Oncology Pharma, Inc. (the "Company") is laying out and taking necessary steps to move its licensed IP forward. From obtaining the necessary financing, in order to support studies, to obtaining the data utilizing mouse or rat clinical trials ("Mouse clinical trials" or "MCT") all steps are being established. The Company has decided to pursue moving forward with...

Read more

Sense Appoints Timothy I. Still as President, CEO and Board Member

July 20, 2021 4:00 AM

Appointment of industry veteran to accelerate commercialization of company's instrument-free molecular testing platform CAMBRIDGE, UK / ACCESSWIRE / July 20, 2021 / Sense Biodetection, innovator of instrument-free, rapid molecular tests that enable improved patient access and enhanced clinical value through patient-focused decentralized testing, today announced the appointment of Timothy I. Still as President and Chief Executive Officer. Still...

Read more

Applied UV and Lootah Batta Water and Environment Sign Exclusive Distribution Agreement for Airocide(R) Air Purification Systems for the United Arab Emirates

July 19, 2021 8:30 AM

MOUNT VERNON, NY / ACCESSWIRE / July 19, 2021 / Applied UV, Inc. (NasdaqCM:AUVI) ("Applied UV" or the "Company"), an infection control technology company that applies the power of narrow-range ultraviolet light ("UVC") for surface areas and catalytic bioconversion technology for air purification to destroy pathogens safely, thoroughly, and automatically, today announced the signing of an exclusive distribution agreement with Lootah Batta Water...

Read more

EV Biologics NFT Dividend Update

July 19, 2021 8:00 AM

NASHVILLE, TN / ACCESSWIRE / July 19, 2021 / EV Biologics Corp, OTC PINK:YECO, today updated shareholders about its NFT dividend. On July 14, 2021 the Company announced a dividend of 1 NFT for every 100 shares of YECO common stock. The NFTs will be distributed via a special dividend to YECO's shareholders of record on July 30, 2021. Shareholders possessing less than 100 shares will not be eligible for this special dividend. MS Token is currently...

Read more

Black Bird Biotech Announces MiteXstream Summer Field Testing on Mite-Plagued Vegetable Crops in Israel by International Agri-Chem Company

July 19, 2021 7:30 AM

FLOWER MOUND, TX / ACCESSWIRE / July 19, 2021 / Black Bird Biotech, Inc. (OTC PINK:BBBT), manufacturer of plant-based MiteXstreamTM biopesticide, today announced that an international agri-chemical company will begin field testing MiteXstream in Israel later this summer, when the rise of mite populations occurs, with testing completion expected in early October. The testing is slated to be conducted on eggplant and cucumber crops, vegetables...

Read more

Black Bird Biotech (BBBT) President to Appear on Newsmax TV’s New to the Street, Sunday, July 18, 2021, 10-11 AM ET

July 17, 2021 11:00 AM

FLOWER MOUND, TX / ACCESSWIRE / July 17, 2021 / Black Bird Biotech, Inc. (OTC PINK:BBBT), manufacturer of plant-based MiteXstreamTM biopesticide, confirmed that its President, Fabian Deneault, will appear on FMW Media's nationally syndicated program, New to the Street, on Newsmax TV tomorrow, Sunday, July 18, 2021, from 10-11 am Eastern Time. For news and updates, shareholders, prospective investors and prospective business partners are...

Read more

Thermic Science Prepares to File the New Rule 15c2-11 Amendments Ahead of Schedule, the September 2021 Deadline for Required Financials & Filings Will Bring the Company Current and in Compliance With the OTC Market Reporting Changes

July 16, 2021 3:10 PM

NASHVILLE, TN / ACCESSWIRE / July 16, 2021 / Thermic Science International Corporation, formerly known as Omnicanna Health Solutions, Inc. aka ENDOCAN CORP. (WKN: A1W61J) (ISIN:US29271J1097) (OTC PINK:ENDO), is pleased to announce that the company has completed its required compliance financials and reporting records to bring the company current and filed ahead of schedule for the September 2021 deadline for the New Rule 15c2-11 Amendments...

Read more

Applied UV, Inc. Announces Closing of $12.0 Million Public Offering of 10.5% Series A Cumulative Perpetual Preferred Stock

July 16, 2021 12:15 PM

MOUNT VERNON, NY / ACCESSWIRE / July 16, 2021 / Applied UV, Inc. (NASDAQ:AUVI) ("Applied UV" or the "Company"), an infection prevention technology company that applies the power of narrow-range ultra violet light ("UVC") to destroy pathogens safely, thoroughly, and automatically, today announced the closing of its underwritten registered public offering of 480,000 shares of 10.5% Series A Cumulative Perpetual Preferred Stock, with liquidation...

Read more

Apollo Endosurgery Appoints Jeffrey G. Black as Chief Financial Officer

July 16, 2021 7:00 AM

Veteran Executive Brings 30 Years of Financial and Operational Leadership Experience AUSTIN, TX / ACCESSWIRE / July 16, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally invasive medical devices for gastrointestinal and bariatric procedures, today announced the hiring of Jeffrey G. Black as Chief Financial Officer. Mr. Black has served as Chief Financial Officer for a variety of publicly-traded companies in...

Read more

Lexaria Completes Successful Antiviral Drug Molecular Characterization Study With Canada's National Research Council

July 15, 2021 7:05 AM

VIRAL-MC21-1 Demonstrates Stability of DehydraTECH™-Enabled Antiviral Drugs KELOWNA, BC / ACCESSWIRE / July 15, 2021 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms is pleased to announce results from its antiviral drug molecular characterization study VIRAL-MC21-1 recently completed by Canada's premier federally funded research organization, the National Research...

Read more

Viewpoint Molecular Targeting(R) Appoints Amos Hedt as Chief Business Strategy Officer

July 14, 2021 10:00 AM

Well-established research professional with expertise in early-stage pharmaceutical and biotechnology drug development Company driving advancement of proprietary image-guided alpha-particle radiotherapies designed to optimize treatment, improve efficacy, and minimize the toxicity associated with many other cancer drugs CORALVILLE, IA / ACCESSWIRE / July 14, 2021 / Viewpoint Molecular Targeting, Inc. ("Viewpoint" or the "Company"), a...

Read more

Applied UV's EU Distributor, Abiotec of France, Announces Airocide(R) Installations in Palace of Versailles to Protect Staff and Art

July 14, 2021 8:30 AM

MOUNT VERNON, NY / ACCESSWIRE / July 14, 2021 / Applied UV, Inc. (NASDAQ:AUVI) ("Applied UV" or the "Company"), an infection control technology company that applies the power of narrow-range ultraviolet light ("UVC") for surface areas and catalytic bioconversion technology for air purification to destroy pathogens safely, thoroughly, and automatically, announced that its European distributor, Abiotec of France, has installed Airocide® units in...

Read more

EV Biologics Announces NFT Dividend

July 14, 2021 8:00 AM

CHEYENNE, WY / ACCESSWIRE / July 14, 2021 / EV Biologics Corp, OTC PINK:YECO, today announced that it will distribute a dividend of one (1) Non-Fungible Token (NFT) for every 100 shares of YECO common stock held on the record date. Shareholders possessing less than 100 shares will not be eligible for this special dividend. The NFTs will be given via a dividend to YECO's shareholders of record on July 30, 2021. CEO Daniel Mckinney said, 'This is...

Read more

Hillstream BioPharma Expands the Scientific Advisory Board with the Addition of Leading Innovator in the Study of Ferroptosis and Cancer, Scott Dixon, Ph.D.

July 13, 2021 9:30 AM

World leader in the study of iron mediated cell death (IMCD)/ferroptosis, a novel cell death pathway used by cancer cells especially in drug resistant tumors BRIDGEWATER, NJ / ACCESSWIRE / July 13, 2021 / Hillstream BioPharma, Inc. ("Hillstream", the "Company") today announced the expansion of the Scientific Advisory Board (SAB) with the addition of Scott J. Dixon, Ph.D., Associate Professor, Biology, Stanford University and Faculty Fellow of...

Read more